ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2025, Vol 15, No. 3

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of integrative fields within Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Why Publish with APB?

Free of charge publication for all article types
Fast and constructive peer review
Simple and efficient online submission
Author-friendly review process
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Research Article

1. Investigating Effect of Rapamycin and Metformin on Angiogenesis in Hepatocellular Carcinoma Cell Line

Mandana Rastegar, Haji-Amin Marjani, Yaghoub Yazdani, Majid Shahbazi, Masoud Golalipour*, Touraj Farazmandfar*

Adv Pharm Bull. 2018;8(1): 63-68. doi: 10.15171/apb.2018.008

PMCID: PMC5899784 PMID: 29670840 Scopus ID: 85044043482

Article

PDF

XML

Cited By:

Short Communication

2. Kaempferol-Mediated Sensitization Enhances Chemotherapeutic Efficacy of Sorafenib Against Hepatocellular Carcinoma: An In Silico and In Vitro Approach

Bhagyalakshmi Nair , Ruby John Anto, Sabitha M, Lekshmi R. Nath*

Adv Pharm Bull. 2020;10(3): 472-476. doi: 10.34172/apb.2020.058

PMCID: PMC7335979 PMID: 32665908 Scopus ID: 85088613671

Article

PDF

Full Text

XML

Cited By:

Research Article

3. The Effect of Alpha Mangostin on Epithelial-Mesenchymal Transition on Human Hepatocellular Carcinoma HepG2 Cells Surviving Sorafenib via TGF-β/Smad Pathways

Syarinta Adenina , Melva Louisa* , Vivian Soetikno, Wawaimuli Arozal, Septelia Inawati Wanandi

Adv Pharm Bull. 2020;10(4): 648-655. doi: 10.34172/apb.2020.078

PMCID: PMC7539313 PMID: 33062605 Scopus ID: 85090440518

Article

PDF

Full Text

XML

Cited By:

Review Article

4. Nanomedicine Strategies Utilizing Lipid-Based Nanoparticles for Liver Cancer Therapy: Exploring Signaling Pathways and Therapeutic Modalities

Fereshteh Asgharzadeh , Maryam Moradi Binabaj, Sahar Fanoudi, William C. Cho, Yu-jeong Yang, Maryam Azarian, Mehdi Shafiee Ardestani, Nasim Nasiri, Marzieh Ramezani Farani* , Yun Suk Huh*

Adv Pharm Bull. 2024;14(3): 513-523. doi: 10.34172/apb.2024.061

PMCID: PMC11530870 PMID: 39494254

Article

PDF

Full Text

XML

Cited By:

Research Article

5. Cell Therapy Using Anti-NKG2A Pretreated Natural Killer Cells in Patients with Hepatocellular Carcinoma

Shirin Tavakoli , Maryam Samareh-Salavati, Shahrokh Abdolahi, Javad Verdi, Iman Seyhoun, Nasim Vousooghi, Mohammad Vaezi, Afshin Ghaderi, Ardeshir Ghavamzadeh, Maryam Barkhordar* , Mohammad Ahmadvand*

Adv Pharm Bull. 2024;14(4): 918-926. doi: 10.34172/apb.43869

PMCID: PMC11970500 PMID: 40190667

Article

PDF

Full Text

XML

Cited By: